Search
Leader | 00000nz a2200037n 45 0 | ||
---|---|---|---|
001 | WKP|Q85471057 (VIAF cluster) (Authority/Source Record) | ||
003 | WKP | ||
005 | 20241221010855.0 | ||
008 | 241221nneanz||abbn n and d | ||
035 | ‡a (WKP)Q85471057 | ||
024 | ‡a 0000-0002-6104-5902 ‡2 orcid | ||
035 | ‡a (OCoLC)Q85471057 | ||
100 | 0 | ‡a Margarida Brito ‡c researcher ‡9 en | |
400 | 0 | ‡a Margarida Brito ‡c wetenschapper ‡9 nl | |
670 | ‡a Author's Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study. | ||
909 | ‡a (orcid) 0000000261045902 ‡9 1 | ||
919 | ‡a comparisonofeffectivenessofbiosimilarfilgrastimnivestimtmreferenceamgenfilgrastimandpegfilgrastiminfebrileneutropeniaprimarypreventioninbreastcancerpatientstreatedwithneoadjuvanttacanoninterventionalcohortstudy ‡A Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study. ‡9 1 | ||
996 | ‡2 LC|nb2005012280 | ||
996 | ‡2 PTBNP|1819143 | ||
996 | ‡2 BNE|XX904637 | ||
996 | ‡2 ISNI|0000000070910211 | ||
996 | ‡2 ISNI|0000000070505849 | ||
996 | ‡2 PTBNP|17500 | ||
996 | ‡2 BLBNB|000153975 | ||
996 | ‡2 PTBNP|407883 | ||
996 | ‡2 ISNI|0000000000551719 | ||
996 | ‡2 PTBNP|1404139 | ||
996 | ‡2 DNB|1318466938 | ||
996 | ‡2 ISNI|0000000069620823 | ||
996 | ‡2 PTBNP|1235487 | ||
996 | ‡2 ISNI|0000000070821606 | ||
996 | ‡2 ISNI|0000000034080679 | ||
996 | ‡2 ISNI|0000000066575334 | ||
996 | ‡2 PTBNP|1307192 | ||
996 | ‡2 LC|no 99044019 | ||
996 | ‡2 BNF|12321032 | ||
996 | ‡2 ISNI|0000000077870953 | ||
996 | ‡2 PTBNP|1222633 | ||
996 | ‡2 PTBNP|24022 | ||
996 | ‡2 SUDOC|195819659 | ||
996 | ‡2 ISNI|0000000068914694 | ||
996 | ‡2 PTBNP|27900 | ||
997 | ‡a 0 0 lived 0 0 ‡9 1 |